{
 "drug": "Docetaxel Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "02/20/2026",
 "dayN": 186,
 "cat": "Oncology",
 "companies": [
  "Ingenus Pharmaceuticals LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "02/20/2026",
   "update_type": "New",
   "initial_posting_date": "02/20/2026",
   "package_ndc": "50742-463-16",
   "generic_name": "Docetaxel Injection",
   "contact_info": "866-321-5031",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "update_date": "02/20/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16)",
   "company_name": "Ingenus Pharmaceuticals LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/20/2026",
   "update_type": "New",
   "initial_posting_date": "02/20/2026",
   "package_ndc": "50742-431-08",
   "generic_name": "Docetaxel Injection",
   "contact_info": "866-321-5031",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "update_date": "02/20/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08)",
   "company_name": "Ingenus Pharmaceuticals LLC",
   "status": "To Be Discontinued"
  }
 ]
}